Home Tools
Log in
Cart

Valrubicin

Catalog No. T7604   CAS 56124-62-0
Synonyms: Valstar, AD-32

Valrubicin (AD-32) (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Valrubicin Chemical Structure
Valrubicin, CAS 56124-62-0
Pack Size Availability Price/USD Quantity
1 mg In stock $ 64.00
5 mg In stock $ 155.00
10 mg In stock $ 229.00
25 mg In stock $ 388.00
50 mg In stock $ 566.00
100 mg In stock $ 790.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 97.41%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Valrubicin (AD-32) (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.
Targets&IC50 PKC (TPA-activated):0.85 μM, PKC (PDBu-induced):1.25 μM
In vitro Valrubicin inhibits the binding of [3H]PDBu to PKC. Therefore, Valrubicin competes with the tumor promoter for the PKC binding site and prevents the latter from both interacting with the phospholipid and binding to PKC [1]. Valrubicin shows cytotoxic activity against squamous cell carcinoma (SCC) cell line colony formation, with IC50s and IC90s of 8.24 μM and 14.81 μM for UMSCC5 cells, 15.90 μM, 29.84 μM for UMSCC5/CDDP? cells, and 10.50 μM, 19.00 μM for UMSCC10b cells, respectively [2].
In vivo Valrubicin, administered at doses of 3, 6, or 9 mg, effectively reduces tumor growth through intratumoral injections in hamsters by the third week. When 6 mg of Valrubicin is used in conjunction with minimally cytotoxic irradiation (ranging from 150, 250, or 350 cGy), it induces significant tumor shrinkage in the hamster model [2]. Additionally, at a concentration of 0.1 μg/μL, Valrubicin markedly decreases the infiltration of neutrophils in TPA-challenged biopsies at 24 hours and mitigates chronic inflammation in mice. Furthermore, Valrubicin reduces the expression of inflammatory cytokines in the acute experimental setup [3].
Cell Research UMSCC5 cells exposed to Valrubicin (2 μM for 3 h), a single dose of radiation (400 cGy), or the combined treatment are cultured for a further 12, 24, or 48 hours. At these times, the cells are collected by trypsinization (0.25%), washed in PBS, and fixed at 5 × 10^6 cells/mL with 95% ethanol. Cells are incubated with ribonuclease (50 μg; 70-90 Kunitz units/mg for 30 min), and the resulting pellet resuspended in and incubated with propidium iodide (0.05 mg/mL for 10 min). The DNA content of the samples is determined by flow cytometry according to standard technique [2].
Animal Research Hamsters with cheek pouch tumors of 100 mm2 are randomly assigned to one of five treatment groups. Momentarily anesthetized animals each receives once a week × 3 injections (27 g × 0.5-inch needle: 0.1 mL administered slowly to the base of the lesion) of Valrubicin (3, 6, or 9 mg) or drug vehicle (Cremophor: alcohol;1:1 by volume; NaCl diluent 12). A further group of animals receives anesthesia but no direct tumor treatment (control). Individual tumor sizes are measured with calipers at weekly intervals for 4 weeks, at which time the animals are sacrificed [2].
Synonyms Valstar, AD-32
Molecular Weight 723.64
Formula C34H36F3NO13
CAS No. 56124-62-0

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 125 mg/mL (172.74 mM)

H2O: Insoluble

TargetMolReferences and Literature

1. Chuang LF, et al. Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32). Biochem Pharmacol. 1992 Feb 18;43(4):865-72. 2. Wani MK, et al. Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck. Laryngoscope. 2000 Dec;110(12):2026-32. 3. Hauge E, et al. Topical valrubicin application reduces skin inflammation in murine models. Br J Dermatol. 2012 Aug;167(2):288-95.

Related compound libraries

This product is contained In the following compound libraries:
Anti-Cancer Approved Drug Library Inhibitor Library Anti-Cancer Clinical Compound Library FDA-Approved Kinase Inhibitor Library Kinase Inhibitor Library Anti-Cancer Active Compound Library Anti-Cancer Drug Library Drug Repurposing Compound Library TGF-beta/Smad Compound Library FDA-Approved & Pharmacopeia Drug Library

Related Products

Related compounds with same targets
Sulfacetamide sodium monohydrate Rifabutin Berberine Aloperine Majoranaquinone Mitomycin A SF2312 ammonium Wortmannin

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Valrubicin 56124-62-0 Chromatin/Epigenetic Cytoskeletal Signaling Microbiology/Virology Antibiotic PKC Inhibitor Valstar inhibit AD-32 AD 32 Protein kinase C AD32 inhibitor

 

TargetMol